Private equity investor Baring PE Asia now has three IT services companies in its portfolio: Hexaware, the erstwhile NIIT Technologies (now Coforge) and most recently, US-based and NASDAQ-listed Virtusa.
The PE firm acquired Virtusa for $2 billion last week. It acquired NIIT Technologies in 2019 and Hexaware in 2013.
The company is currently in the middle of delisting Hexaware from stock exchanges. According analysts Moneycontrol spoke to, the idea is to eventually sell the company. A Mint report has pointed out that delisting came after many failed attempts by the PE firm to find a buyer.
During recent interactions, R Srikrishna, CEO, Hexaware, told Moneycontrol that delisting will have no impact on employees and that the company’s operations will continue as before.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
So, why would Baring PE acquire another IT firm now? Analysts list three reasons:
It is not clear yet what the company’s plans for these firms are. Industry watchers speculate that Baring could integrate all three firms since they can complement each other and become a bigger firm with a combined revenue of over $2.5 billion.
Hexaware registered $793 million in revenue for the financial year ended December 2019. Coforge's annual revenue was about $600 million for the year ended March 31, 2020. Virtusa’s revenue stood at $1.3 billion, also for the year ended March 2020.
All three firms have a huge focus on the banking and financial services segment, and with vendor consolidation underway, combining them could help drive market-share gains.
In addition, each of these companies has its own specialisation and could create a diversified portfolio.
Coforge focusses on insurance as well as travel & hospitality and is now looking to expand into healthcare. For Hexaware, manufacturing & consumer, hi-tech and professional services each accounted for about 16 percent of revenue in the June quarter. Healthcare and insurance accounted for about 21 percent of revenue during the same quarter.
BFSI apart, healthcare and communications & technology at 14 percent and 24 percent, respectively, were the key verticals for Virtusa for the quarter ended June 2020.
Clearly, combining these entities can create a strong healthcare play and at the same time give them diversified service lines.
The sale option
However, it is also possible that Baring PE will help these companies grow individually and sell them.
Jain explained that PE players invest in companies to get better returns. They are not attached to the company the way founders and promoters are and hence are likely to sell when the timing is right, he added.
In that case, it would be difficult selling a combined entity with a huge valuation. “So, they are most likely to grow the companies to a certain scale and then look for a buyer,” he added.
Jain also reasoned that if combining the entity was the focus, there was never any need to de-list Hexaware. So, growing the companies would be the PE firm’s focus, he added.
Coforge is looking to grow to a $1-billion firm in the coming year. In a recent interaction with Moneycontrol, Sudhir Singh, its CEO, said that operations would continue as before and there are no plans for either a merger with Hexaware or for a de-listing.
No roadmap has been announced for Virtusa yet, but growth would be the key focus here as well, added experts.